Genome engineering of stem cell organoids for disease modeling
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Precision medicine emerges as a new approach that takes into account individual variability. Successful realization of precision medicine requires disease models that are able to incorporate personalized disease information and recapitulate disease development processes at the molecular, cellular and organ levels. With recent development in stem cell field, a variety of tissue organoids can be derived from patient specific pluripotent stem cells and adult stem cells. In combination with the state-of-the-art genome editing tools, organoids can be further engineered to mimic disease-relevant genetic and epigenetic status of a patient. This has therefore enabled a rapid expansion of sophisticated in vitro disease models, offering a unique system for fundamental and biomedical research as well as the development of personalized medicine. Here we summarize some of the latest advances and future perspectives in engineering stem cell organoids for human disease modeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These manipulations are easily applied to organoid systems51,66, fuelling a burgeoning interest in the application of this technology to understand the pathophysiology of a wide range of adult and developmental human brain diseases.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · cited 3×
“…that have been successfully generated with ASCs from primary murine or human tissues include intestine (mouse/human) (Dekkers et al., 2013; Sato et al., 2009; Yin et al., 2014), stomach (mouse/human) (Barker et al., 2010; Bartfeld et al., 2015; Schlaermann et al., 2016; Stange et al.,…”
BackgroundCleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659 · cited 2×
“…et al., 2014; Konermann et al., 2015; Gilbert et al., 2014; Shalem et al., 2014; Wang et al., 2014; Zhou et al., 2014), transformation and metastasis of cancer cells (Chen et al., 2015), pyroptotic cell death (Parnas et al., 2015; Shi et al., 2015) or mitochondrial deficiency (Jain et al., 2016).”
BackgroundDevelopment and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Moreover, the emergence of genome editing technologies over the past a few years has made it feasible to efficiently engineer disease relevant genetic variations into stem cells (Hsu et al., 2014; Wang and Qi, 2016).”
BackgroundProgrammable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437 · cited 6×
“Cells react to DSBs by initiating DNA repair processes, either through non-homology end joining (NHEJ) or homology directed recombination (HDR).”
MethodInfluentialCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 3×
“…et al., 2011), inner ear (mouse) (Koehler et al., 2013; Koehler and Hashino, 2014), brain (mouse/human) (Eiraku et al., 2008; Gaspard et al., 2008; Lancaster et al., 2013; Lancaster and Knoblich, 2014; Mariani et al., 2012; Muguruma et al., 2010, 2015; Qian et al., 2016), pituitary gland…”
BackgroundMethodGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 2×
“…or signaling pathways involved in the development of tumor drug resistance (Koike-Yusa et al., 2014; Konermann et al., 2015; Gilbert et al., 2014; Shalem et al., 2014; Wang et al., 2014; Zhou et al., 2014), transformation and metastasis of cancer cells (Chen et al., 2015), pyroptotic cell death…”
BackgroundA New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 2×
“…regulate gene expression at the transcriptional levels (Cheng et al., 2013; Gilbert et al., 2013; Perez-Pinera et al., 2013a; Pinera et al., 2013b; Qi et al., 2013); with epigenetic regulators (e.g. acetyltransferase and histone demethylase) to manipulate the epi-status of a genomic region…”
Background
Cited by
The use of brain organoids to investigate neural development and disease
Di Lullo, E., & Kriegstein, A. R. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.107 · Cited by 788
Gasparini, S. J., Llonch, S., Borsch, O., & Ader, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.001 · Cited by 186
Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells
Ho, B., Pek, N., & Soh, B.-S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040936 · Cited by 182
“Recent advancements in genome editing, such as clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system (CRISPR-Cas9) genome engineering tool, has enabled researchers to efficiently manipulate genomic sequences in hESCs and hiPSCs [4].”
BackgroundChen, L., Qu, J., Cheng, T., Chen, X., & Xiang, C. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1503-7 · Cited by 149
“proved that CRISPR/Cas9 can be applied to many biological organisms with the deep connection of genetically engineered stem cells, factors, and diseases [66].”
Li, X., Zheng, M., Xu, B., Li, D., Shen, Y., Nie, Y., Ma, L., & Wu, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121213 · Cited by 90
Metadata
- Authors
- Sun, Y., & Ding, Q.
- Affiliations
- Chinese Academy of Sciences (CN)
- Corresponding author
- Ding, Qiurong
- ORCID
- Ding, Qiurong
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-19
- Volume
- 8
- Issue
- 5
- Pages
- 315-327
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- PMC
- PMC5413597
- OpenAlex
- W2573519855
- Cited by
- 39
- References
- 108
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 7 · 2017: 3
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Protein & Cell (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31670829, 81600650)
- Chinese Academy of Sciences
- China Postdoctoral Science Foundation (2016M601666)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- genome editing, disease modeling, precision medicine, pluripotent stem cells, adult stem cells, patient-specific disease models, epigenetic engineering, in vitro disease model
- MeSH terms
- Gene Editing, Animals, Humans, Models, Biological, Organoids, Biomedical Research, Pluripotent Stem Cells, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genome engineering of stem cell organoids for disease modeling. https://app.cochat.ai/papers/10.1007/s13238-016-0368-0
- The paper
- Sun, Y., & Ding, Q. (2017). Genome engineering of stem cell organoids for disease modeling. Protein & Cell. https://doi.org/10.1007/s13238-016-0368-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.